Task: Answer the MCQ question.
Query: Which drug exhibits a -0.148% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(C)Sc1nnc(OC(=O)N(C)C)n1-c1ccccc1
b COc1ccc2c([N+](=O)[O-])c(N3CCCC3)[nH]c2c1
c Cc1nc(CN2CCC(c3ccccc3)CC2)cc(=O)[nH]1
Answer: a. CC(C)Sc1nnc(OC(=O)N(C)C)n1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Sc1nnc(OC(=O)N(C)C)n1-c1ccccc1
CC(C)Sc1nnc(OC(=O)N(C)C)n1-c1ccccc1
(4-phenyl-5-propan-2-ylsulfanyl-1,2,4-triazol-3-yl) N,N-dimethylcarbamate